Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Clarke

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Bioorganic & Medicinal Chemistry|December 3, 2014
Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugsAiping Bai, Zdzislaw M Szulc, Jacek Bielawski, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2016
Role of neutral ceramidase in colon cancerMónica García-Barros, Nicolas Coant, Toshihiko Kawamori, et al.
Human Gene Therapy|May 12, 2012
Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brainErnesto A Salegio, Lluis Samaranch, Russell W Jenkins, et al.
European Journal of Pain (London, England)|October 4, 2005
An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute modelsAlex W Wilson, Stephen J Medhurst, Claire I Dixon, et al.
Molecular Cancer Therapeutics|March 29, 2012
Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide inductionMarisa Meyers-Needham, Jocelyn A Lewis, Salih Gencer, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystemsRaafat Chalar, Naheel Khatri, Jowana Obeid, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Neutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor GrowthAndrew E Resnick, Victoria Franzi, Botheina K Ghandour, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
A Critical Role for Neutral Sphingomyelinase-2 in Doxorubicin-induced CardiotoxicitySamia Mohammed, Victoria Alvarado, Ya-Ping Jiang, et al.
Journal of Lipid Research|May 12, 2017
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.
Cancer Immunology Research|March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy EfficacyAnne Montfort, Florie Bertrand, Julia Rochotte, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Bioorganic & Medicinal Chemistry|December 3, 2014
Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugsAiping Bai, Zdzislaw M Szulc, Jacek Bielawski, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2016
Role of neutral ceramidase in colon cancerMónica García-Barros, Nicolas Coant, Toshihiko Kawamori, et al.
Human Gene Therapy|May 12, 2012
Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brainErnesto A Salegio, Lluis Samaranch, Russell W Jenkins, et al.
European Journal of Pain (London, England)|October 4, 2005
An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute modelsAlex W Wilson, Stephen J Medhurst, Claire I Dixon, et al.
Molecular Cancer Therapeutics|March 29, 2012
Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide inductionMarisa Meyers-Needham, Jocelyn A Lewis, Salih Gencer, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystemsRaafat Chalar, Naheel Khatri, Jowana Obeid, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Neutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor GrowthAndrew E Resnick, Victoria Franzi, Botheina K Ghandour, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
A Critical Role for Neutral Sphingomyelinase-2 in Doxorubicin-induced CardiotoxicitySamia Mohammed, Victoria Alvarado, Ya-Ping Jiang, et al.
Journal of Lipid Research|May 12, 2017
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.
Cancer Immunology Research|March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy EfficacyAnne Montfort, Florie Bertrand, Julia Rochotte, et al.
Pageof 9